Clinical Trial Update: Improving Intermediate Risk Management. MARK Study

View source ↗

Summary

The MARK Study trial has completed, reporting results on intermediate risk management in patients with myocardial infarction, angina pectoris, stroke, and perip…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Myocardial Infarction
• Peripheral Arterial Disease
• Stroke

Snippet

Sponsor: Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina | Conditions: Myocardial Infarction, Angina Pectoris | Status: COMPLETED